Travel Medicine Advisor Archives – December 1, 2006
December 1, 2006
View Issues
-
Multidrug-Resistant Tuberculosis (MDR-TB)
The World Health Organization/International Union against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance began collecting its data in 1994 on drug resistance in 90 countries. -
Nitazoxanide for the Treatment of Clostridium difficile Colitis
Oral vancomycin alone or combined with either oral or parenteral metronidazole have been workhorses during the current epidemic of nosocomial Clostridium difficile-associated disease. Vancomycin is actually the only drug approved by the US FDA for this purpose. -
Commercial Air Travel by Prematurely Born Infants
Increasingly, infants with a history of neonatal lung disease are traveling by air. With advancing technology, aircraft are able to fly longer distances at higher altitudes. -
High Altitude Pulmonary Edema Prevention
This is a sentinel article involving a randomized, double-blind, placebo-controlled study which took 29 adult patients with a history of high altitude pulmonary edema (HAPE) from 490 m to an ascent of 4559 m within 24 hours, treating them for 2 days with either prophylactic tadalafil 10 mg orally, twice a day, dexamethasone 8 mg orally twice a day or a placebo twice daily, starting on the morning of ascent. -
Pharmacology Watch: Sweeping Changes Needed for US Drug Safety System
Antiaging Supplements Proven Ineffective; The Three Most Common Culprits of ADE; New Guidelines for Lyme Disease Prevention; FDA Actions